Phase III: Randomized observer-blind trial to evaluate lot-to-lot consistency of a new plant-derived quadrivalent virus like particle influenza vaccine in adults 18–49 years of age
Brian J. Ward, Annie Séguin, Julie Couillard, Sonia Trépanier, Nathalie Landry
Topics & Concepts
MedicineSeroconversionVaccinationInfluenza vaccineHemagglutination assayVirologyPopulationLive attenuated influenza vaccineImmunologyTiterInternal medicineVirusEnvironmental healthTransgenic Plants and ApplicationsInfluenza Virus Research StudiesPlant Virus Research Studies